Muthusamy B - Search Results

1

ADAURA update: only the end of the beginning.

Muthusamy B, Pennell NA. Muthusamy B, et al. Transl Lung Cancer Res. 2023 Jul 31;12(7):1649-1651. doi: 10.21037/tlcr-23-237. Epub 2023 May 22. Transl Lung Cancer Res. 2023. PMID: 37577316 Free PMC article. No abstract available.

2

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.

Catania C, Muthusamy B, Spitaleri G, Del Signore E, Pennell NA. Catania C, et al. Among authors: muthusamy b. Clin Lung Cancer. 2022 Mar;23(2):108-115. doi: 10.1016/j.cllc.2021.11.003. Epub 2021 Nov 11. Clin Lung Cancer. 2022. PMID: 34952792 Review.

3

Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer.

Muthusamy B, Pennell N. Muthusamy B, et al. J Thorac Oncol. 2022 Feb;17(2):179-181. doi: 10.1016/j.jtho.2021.11.012. J Thorac Oncol. 2022. PMID: 35074223 Free article. No abstract available.

4

Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer.

Muthusamy B, Patil PD, Pennell NA. Muthusamy B, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):953-961. doi: 10.6004/jnccn.2022.7021. J Natl Compr Canc Netw. 2022. PMID: 35948038 Review.

5

Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma.

Muthusamy B, Raskina K, Lofgren KT, Li G, Tolba K, Schwed K, Castellanos E, Huang RSP, Oxnard GR, Schrock AB, Pennell N. Muthusamy B, et al. J Thorac Oncol. 2023 Apr;18(4):476-486. doi: 10.1016/j.jtho.2022.11.027. Epub 2022 Dec 6. J Thorac Oncol. 2023. PMID: 36494074 Free article.

6

EGFR mutation testing, treatment and survival in stage I-III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis.

Muthusamy B, Berktas M, Li J, Thomas DS, Sun P, Taylor A, Pennell NA. Muthusamy B, et al. Future Oncol. 2024;20(28):2083-2096. doi: 10.1080/14796694.2024.2347826. Epub 2024 Jun 25. Future Oncol. 2024. PMID: 38916211 Free PMC article.

7

Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.

Acharya NR, Ramanan AV, Coyne AB, Dudum KL, Rubio EM, Woods SM, Guly CM, Moraitis E, Petrushkin HJD, Armon K, Puvanachandra N, Choi JT, Hawley DP, Arnold BF; ADJUST Study Group. Acharya NR, et al. Lancet. 2025 Jan 25;405(10475):303-313. doi: 10.1016/S0140-6736(24)02468-1. Lancet. 2025. PMID: 39863370 Free article. Clinical Trial.

8

PRKN-gene related parkinsonism: An experience from a tertiary centre and literature review of Asian cohort.

Holla VV, Dhar D, Phulpagar P, Samim MM, Kamath SD, Kamble N, Muthusamy B, Yadav R, Pal PK. Holla VV, et al. Among authors: muthusamy b. Can J Neurol Sci. 2025 Jan 16:1-30. doi: 10.1017/cjn.2024.366. Online ahead of print. Can J Neurol Sci. 2025. PMID: 39817443 No abstract available.

9

C19orf12 gene variants causing mitochondrial membrane protein-associated neurodegeneration (MPAN).

Kumari R, Holla VV, Sriram N, Kamble N, Asranna A, Saini J, Arunachal G, Yadav R, Pandey A, Pal PK, Muthusamy B. Kumari R, et al. Among authors: muthusamy b. Eur J Hum Genet. 2025 Jan 4. doi: 10.1038/s41431-024-01778-6. Online ahead of print. Eur J Hum Genet. 2025. PMID: 39755877

10

Genetic architecture of a single cohort of 230 Indian Parkinson's Disease patients.

Kamath SD, Phulpagar P, Holla VV, Kamble N, Yadav R, Muthusamy B, Kumar Pal P. Kamath SD, et al. Among authors: muthusamy b. Parkinsonism Relat Disord. 2024 Dec;129:107157. doi: 10.1016/j.parkreldis.2024.107157. Epub 2024 Sep 27. Parkinsonism Relat Disord. 2024. PMID: 39378566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters